Patents Assigned to ATH Therapeutics Inc.
  • TREATING RESPIRATORY INFECTIONS
    Publication number: 20240181024
    Abstract: A method of treating or preventing a respiratory infection can include delivering aerosolized droplets of an antiviral solution to lung tissue of a subject, the antiviral solution including an aqueous carrier and an ATH conjugate that is solubilized in the aqueous carrier. The ATH conjugate includes antithrombin covalently bonded to heparin, the heparin including a polysaccharide chain having from about 15 to about 1,500 monosaccharide units.
    Type: Application
    Filed: March 25, 2022
    Publication date: June 6, 2024
    Applicant: ATH Therapeutics Inc.
    Inventors: Leslie Roy BERRY, Anthony Kam Chuen CHAN, William JACKSON, Attilio DIFIORE
  • Medical devices, systems, and methods utilizing antithrombin-heparin composition
    Patent number: 11752242
    Abstract: Medical devices, systems, and methods for treating conditions using antithrombin-heparin conjugates are disclosed. For example, medical devices can be coated with antithrombin-heparin (ATH) resulting in reduced thrombogenicity. Various conditions can likewise be treated with ATH.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: September 12, 2023
    Assignee: ATH Therapeutics Inc.
    Inventors: Attilio Difiore, Leslie Roy Berry, Anthony Kam Chuen Chan